Back to list

Heuron Signs Exclusive Distribution Agreement with Japan’s Doctor Net for Stroke Solution

Mar. 2025

 Heuron’s Full-fledged Entry into Japan Begins

Collaboration for Nationwide Distribution and Regulatory Approval in Japan




Photo caption: Heuron and Doctor Net sign an exclusive distribution agreement in Tokyo on the 19th. (From the second left: Heuron’s Vice President & CBO Park Chan-Ik, Doctor Net’s CEO Hasegawa Masako)

 

South Korea’s leading AI-driven neurovascular disease specialist, Heuron Inc.(CEO Shin Dong-Hoon), has signed an exclusive distribution agreement with Doctor Net Inc., a Japanese remote diagnostic imaging company, on February 19 in Tokyo.

 

The signing ceremony was attended by Park Chan-Ick, Vice President and CBO of Heuron, and Hasegawa Masako, CEO of Doctor Net.

 

Doctor Net, Japan’s largest remote diagnostic imaging company, provides AI-powered medical imaging analysis services and a cloud-based medical data system through its advanced AI medical platform.

 

With this agreement, Heuron will distribute and sell its non-contrast CT-based acute stroke triage AI solution, "Heuron StroCare Suite™," across hospitals and medical institutions throughout Japan. Additionally, both companies will closely collaborate to obtain regulatory approval for the solution within Japan by the end of the year.

 

Shin Dong-Hoon, CEO of Heuron, stated, "This partnership with Doctor Net marks the beginning of Heuron’s expansion into the Japanese market. We are committed to ensuring that our solution is not only recognized in South Korea but also in Japan and the global market. Heuron will continue to drive clinical innovation and research to benefit more patients and healthcare professionals worldwide.”

Back to list

TOP